Literature DB >> 31730286

Blood pressure control according to clinical practice guidelines is associated with decreased mortality and cardiovascular events among liver transplant recipients.

Lisa B VanWagner1,2,3, Jane L Holl4, Samantha Montag2, Dyanna Gregory1, Sean Connolly1, Megan Kosirog1, Patrick Campbell1, Stewart Pine1, Amna Daud3, Dan Finn1, Daniela Ladner3, Anton I Skaro5, Josh Levitsky1,3, Donald M Lloyd-Jones6.   

Abstract

Data for liver transplant recipients (LTRs) regarding the benefit of care concordant with clinical practice guidelines for management of blood pressure (BP) are sparse. This paper reports on clinician adherence with BP clinical practice guideline recommendations and whether BP control is associated with mortality and cardiovascular events (CVEs) among LTRs. We conducted a longitudinal cohort study of adult LTRs who survived to hospital discharge at a large tertiary care network between 2010 and 2016. The primary exposure was a BP of <140/<90 mm Hg within year 1 of LT. Among 602 LTRs (mean age 56.7 years, 64% men), 92% had hypertension and 38% had new onset hypertension. Less than 30% of LTRs achieved a BP of <140/<90 mm Hg over a mean of 43.2 months. In multivariable models, adjusted for key confounders, BP control post-LT compared with lack of control was associated with a significantly lower hazard of mortality (hazard ratio [HR] 0.48, 95% confidence interval [CI] 0.39, 0.87) and of CVEs (HR 0.65, 95% CI 0.43, 0.97). The association between BP control of <140/<90 mm Hg with improved survival and decreased CVEs in LTRs suggests that efforts to improve clinician adherence to BP clinical practice recommendations should be intensified.
© 2019 The American Society of Transplantation and the American Society of Transplant Surgeons.

Entities:  

Keywords:  cardiovascular disease; clinical research/practice; health services and outcomes research; hypertension/antihypertensives; liver transplantation/hepatology

Mesh:

Year:  2019        PMID: 31730286      PMCID: PMC7042060          DOI: 10.1111/ajt.15706

Source DB:  PubMed          Journal:  Am J Transplant        ISSN: 1600-6135            Impact factor:   8.086


  30 in total

Review 1.  Metabolic syndrome and liver transplantation: a review and guide to management.

Authors:  Kymberly D S Watt; Michael R Charlton
Journal:  J Hepatol       Date:  2010-03-31       Impact factor: 25.083

2.  All-or-none measurement raises the bar on performance.

Authors:  Thomas Nolan; Donald M Berwick
Journal:  JAMA       Date:  2006-03-08       Impact factor: 56.272

3.  Long-term management of the successful adult liver transplant: 2012 practice guideline by the American Association for the Study of Liver Diseases and the American Society of Transplantation.

Authors:  Michael R Lucey; Norah Terrault; Lolu Ojo; J Eileen Hay; James Neuberger; Emily Blumberg; Lewis W Teperman
Journal:  Liver Transpl       Date:  2013-01       Impact factor: 5.799

4.  2014 evidence-based guideline for the management of high blood pressure in adults: report from the panel members appointed to the Eighth Joint National Committee (JNC 8).

Authors:  Paul A James; Suzanne Oparil; Barry L Carter; William C Cushman; Cheryl Dennison-Himmelfarb; Joel Handler; Daniel T Lackland; Michael L LeFevre; Thomas D MacKenzie; Olugbenga Ogedegbe; Sidney C Smith; Laura P Svetkey; Sandra J Taler; Raymond R Townsend; Jackson T Wright; Andrew S Narva; Eduardo Ortiz
Journal:  JAMA       Date:  2014-02-05       Impact factor: 56.272

Review 5.  Keys to long-term care of the liver transplant recipient.

Authors:  Kymberly D Watt
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2015-10-13       Impact factor: 46.802

Review 6.  Diabetes and Hypertension: A Position Statement by the American Diabetes Association.

Authors:  Ian H de Boer; Sripal Bangalore; Athanase Benetos; Andrew M Davis; Erin D Michos; Paul Muntner; Peter Rossing; Sophia Zoungas; George Bakris
Journal:  Diabetes Care       Date:  2017-09       Impact factor: 19.112

7.  OPTN/SRTR 2017 Annual Data Report: Liver.

Authors:  W R Kim; J R Lake; J M Smith; D P Schladt; M A Skeans; S M Noreen; A M Robinson; E Miller; J J Snyder; A K Israni; B L Kasiske
Journal:  Am J Transplant       Date:  2019-02       Impact factor: 8.086

8.  The interaction among donor characteristics, severity of liver disease, and the cost of liver transplantation.

Authors:  Paolo R Salvalaggio; Nino Dzebisashvili; Kara E MacLeod; Krista L Lentine; Adrian Gheorghian; Mark A Schnitzler; Samuel Hohmann; Dorry L Segev; Sommer E Gentry; David A Axelrod
Journal:  Liver Transpl       Date:  2011-03       Impact factor: 5.799

9.  Randomized trial of tacrolimus in combination with sirolimus or mycophenolate mofetil in kidney transplantation: results at 6 months.

Authors:  Thomas Gonwa; Robert Mendez; Harold C Yang; Samuel Weinstein; Stephen Jensik; Steven Steinberg
Journal:  Transplantation       Date:  2003-04-27       Impact factor: 4.939

10.  Factors Associated With Major Adverse Cardiovascular Events After Liver Transplantation Among a National Sample.

Authors:  L B VanWagner; M Serper; R Kang; J Levitsky; S Hohmann; M Abecassis; A Skaro; D M Lloyd-Jones
Journal:  Am J Transplant       Date:  2016-03-29       Impact factor: 8.086

View more
  10 in total

Review 1.  Management of cardiac diseases in liver transplant recipients: Comprehensive review and multidisciplinary practice-based recommendations.

Authors:  Manhal Izzy; Brett E Fortune; Marina Serper; Nicole Bhave; Andrew deLemos; Juan F Gallegos-Orozco; Cesar Guerrero-Miranda; Shelley Hall; Matthew E Harinstein; Maria G Karas; Michael Kriss; Nicholas Lim; Maryse Palardy; Deirdre Sawinski; Emily Schonfeld; Anil Seetharam; Pratima Sharma; Jose Tallaj; Darshana M Dadhania; Lisa B VanWagner
Journal:  Am J Transplant       Date:  2022-03-31       Impact factor: 9.369

Review 2.  Current Concepts of Cirrhotic Cardiomyopathy.

Authors:  Manhal J Izzy; Lisa B VanWagner
Journal:  Clin Liver Dis       Date:  2021-03-10       Impact factor: 6.126

Review 3.  Cardiac and Pulmonary Vascular Risk Stratification in Liver Transplantation.

Authors:  Blessing Aghaulor; Lisa B VanWagner
Journal:  Clin Liver Dis       Date:  2020-10-26       Impact factor: 6.126

4.  Liver Transplant Recipient, Caregiver, and Provider Perceptions of Cardiovascular Disease and Related Risk Factors After Transplant.

Authors:  Lisa B VanWagner; Elisa Gordon; Lindsay Adamski; Megan Kosirog; Amna Daud; Daniel J Finn; Donald M Lloyd-Jones; Jane L Holl
Journal:  Liver Transpl       Date:  2021-05       Impact factor: 5.799

5.  When evidence is lacking: a mixed-methods approach for the development of practice guidance in liver transplantation.

Authors:  Lisa B VanWagner; Blessing Aghaulor; Tasmeen Hussain; Megan Kosirog; Patrick Campbell; Stewart Pine; Amna Daud; Daniel J Finn; Josh Levitsky; Donald M Lloyd-Jones; Jane L Holl
Journal:  Gastroenterol Rep (Oxf)       Date:  2020-12-10

6.  The Role of Arterial Stiffness in the Estimation of Cardiovascular Risk in Liver Transplant Recipients.

Authors:  Lydia Sastre; Raquel García; Julián-Gonzalo Gándara; Patricia Fernández-Llama; Antonio J Amor; Cristina Sierra; Laia Escudé; Pablo Ruiz; Jordi Colmenero; Emilio Ortega; Miquel Navasa; Gonzalo Crespo
Journal:  Transplant Direct       Date:  2021-12-23

Review 7.  Current aspects of renal dysfunction after liver transplantation.

Authors:  Mariana P Pacheco; Luiz Augusto Carneiro-D'Albuquerque; Daniel F Mazo
Journal:  World J Hepatol       Date:  2022-01-27

8.  Comanagement With Nephrologist Care Is Associated With Fewer Cardiovascular Events Among Liver Transplant Recipients With Chronic Kidney Disease.

Authors:  Patrick T Campbell; Megan Kosirog; Blessing Aghaulor; Dyanna Gregory; Stewart Pine; Amna Daud; Arighno Das; Daniel J Finn; Josh Levitsky; Jane L Holl; Donald M Lloyd-Jones; Lisa B VanWagner
Journal:  Transplant Direct       Date:  2021-09-20

9.  Barriers to Clinical Practice Guideline Implementation Among Physicians: A Physician Survey.

Authors:  Bashar Qumseya; April Goddard; Amira Qumseya; David Estores; Peter V Draganov; Christopher Forsmark
Journal:  Int J Gen Med       Date:  2021-11-02

Review 10.  Cardiac Risk Assessment in Liver Transplant Candidates: Current Controversies and Future Directions.

Authors:  Pranab M Barman; Lisa B VanWagner
Journal:  Hepatology       Date:  2021-06       Impact factor: 17.298

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.